Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331678 · ClinicalTrials.gov registry record · NA
Evaluation of a Mobile App to Promote Social Support for Oncology Patients
A NA study of Chemotherapy Effect, sponsored by West Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 3
- Study locations
NCT04331678 is a NA study of Chemotherapy Effect that has completed, run by West Cancer Center. The registered enrollment target is 230 participants, above the 71-participant average among 7 other Chemotherapy Effect trials with a reported enrollment target (224% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT04331678, a NA study of Chemotherapy Effect, has completed, sponsored by West Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 3
- Study locations
Study Summary
Our study will evaluate patient and caregiver use of a new mobile application (app) to support patients undergoing chemotherapy treatment for cancer.
Conditions Studied
Interventions
- BEHAVIORAL Comparator App
Study Locations (3)
Tennessee
- West Cancer Center - Germantown
- West Cancer Center - Memphis
Mississippi
- West Cancer Center - Southaven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2021-10-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04331678
The ClinicalTrials.gov registry entry for NCT04331678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 7 other Chemotherapy Effect trials with a reported enrollment target (224% higher). The listed sponsor is West Cancer Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chemotherapy Effect appearing as the primary indexed condition, and to 1 intervention - of which Comparator App is the first listed.
NCT04331678 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Mississippi.
Frequently Asked Questions
What is clinical trial NCT04331678 about?
NCT04331678 is a clinical study titled "Evaluation of a Mobile App to Promote Social Support for Oncology Patients". Our study will evaluate patient and caregiver use of a new mobile application (app) to support patients undergoing chemotherapy treatment for cancer.
What is the current status of trial NCT04331678?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2020-03-12. Estimated completion is 2021-10-24.
What conditions does trial NCT04331678 study?
This clinical trial studies the following conditions: Chemotherapy Effect.
What interventions are being tested in trial NCT04331678?
The interventions under investigation include: Comparator App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04331678?
This trial is sponsored by West Cancer Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04331678 being conducted?
This trial has 3 study locations across Mississippi, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy Effect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improve Cancer-related Cognitive Impairment
RECRUITING · NA
-
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
RECRUITING · NA
-
FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study
COMPLETED · NA
-
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.